TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

TANABE PHARMA

MetabolicInfectious DiseaseImmunology
Pharma

TANABE PHARMA is a pharmaceutical company focused on Metabolic, Infectious Disease, Immunology. Key products include RADICAVA.

2017
Since
1
Drugs
-
Trials
0
Approved (2yr)

Key Drugs

RADICAVA
edaravone
CNS
1 indications · 2017

Recent Activity

No recent activity
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Metabolic 41%
0 drugs Phase 3: 4
Infectious Disease 21%
0 drugs Phase 3: 2
Immunology 18%
0 drugs Phase 2: 3 Phase 1: 1
Gastroenterology 10%
0 drugs Phase 1: 4
Neurology 10%
0 drugs Phase 2: 2

Pipeline Strength Pro

Loading...

Competitors Pro

Bristol-Myers Squibb big-pharma
Immunology, Gastroenterology, Infectious Disease, Neurology
Pfizer big-pharma
Infectious Disease, Immunology, Gastroenterology
Takeda big-pharma
Immunology, Gastroenterology, Neurology, Metabolic
Merck big-pharma
Infectious Disease, Immunology, Metabolic
AbbVie big-pharma
Immunology, Neurology, Infectious Disease